c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle - PubMed (original) (raw)

c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle

J J Ryan et al. Proc Natl Acad Sci U S A. 1994.

Abstract

We have studied the ability of c-myc and bcl-2 oncogenes to modulate p53 function. Our studies show that coincident expression of human Bcl-2 protein with p53 prolongs survival of murine erythroleukemia cells. This effect was associated with a loss of the G1 specificity of p53-mediated cell cycle arrest. Furthermore, we found that the c-myc and bcl-2 genes cooperate to inhibit p53 functions. Coexpression of bcl-2 and c-myc can totally overcome p53-induced apoptosis and cell cycle arrest by altering the subcellular trafficking of p53 during the cell cycle: the p53 remains in the cytoplasm of the cotransfected cells during a critical period in G1. This finding suggests a mechanism by which normal hematopoietic progenitors can survive and proliferate despite p53 expression and by which the inappropriate expression of bcl-2 and c-myc can cooperate in transformation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6 - PubMed
    1. Cell. 1992 Jul 10;70(1):153-61 - PubMed
    1. Nature. 1992 Oct 8;359(6395):552-4 - PubMed
    1. Nature. 1992 Nov 12;360(6400):177-9 - PubMed
    1. Mol Cell Biol. 1993 Jan;13(1):711-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources